プロテオミクスサービス市場：タイプ別、サンプルタイプ別、サービスタイプ別、テクノロジー別、アプリケーション別、エンドユーザー別-2025-2030年世界予測

プロテオミクスサービス市場は、2024年に55億2,000万米ドルと評価され、2025年には61億3,000万米ドル、CAGR 11.34％で成長し、2030年には105億1,000万米ドルに達すると予測されています。

プロテオミクス・サービスは、現代のライフサイエンスとバイオテクノロジーにおける重要な柱として登場し、細胞プロセスと疾病メカニズムの理解方法を再定義しています。プロテオーム（生物が発現するタンパク質全体）を分析することで、科学者は基礎研究と臨床応用の両方を推進する貴重な洞察を得ることができます。今日のペースの速い研究環境において、プロテオミクス・サービスは技術革新と科学的発見のユニークな融合を提供し、研究者が複雑な生物学的システムをかつてない精度で解読することを可能にします。

近年の分析技術、データ処理、ハイスループットスクリーニングの進歩により、プロテオミクスは個別化医療、バイオマーカー探索、創薬の最前線に位置づけられるようになりました。この進化は、学術研究を変容させるだけでなく、製薬、バイオテクノロジー、臨床診断などの産業が採用する戦略をも再構築しています。研究機関や営利企業が複雑な生物学的課題に立ち向かい続ける中、信頼性が高く効率的でスケーラブルなプロテオミクスサービスに対する需要はかつてないほど高まっています。

この市場のダイナミックな性質は、技術への継続的な投資と、包括的なタンパク質分析を可能にする最先端の機器開発に由来します。これらの革新的な手法は、タンパク質の正確な同定と定量に役立つため、標的を絞った治療介入に新たな道を開くことになります。全体として、プロテオミクスの状況における進行中のシフトは、利害関係者にとって、科学的発見を推進すると同時に、アンメット・クリニカル・ニーズに対応する大きな機会を提供しています。

プロテオミクスサービス市場の変革

プロテオミクス・サービスの分野は、科学的調査の実施方法に革命をもたらす変革期を迎えています。過去10年間、急速な技術の進歩により、タンパク質分析の精度、拡張性、スピードが向上し、発見と応用の新時代が到来しました。このようなシフトの中心にあるのは、信頼性を損なうことなくハイスループット分析をサポートする堅牢な分析フレームワークと最先端の装置の統合です。

次世代質量分析計や高度なクロマトグラフィー技術などの革新により、研究者はタンパク質発現の最も微妙な変化でさえも、より高い分解能と感度で検出できるようになりました。これらの進歩は、従来の手作業による方法から、エラーを減らし再現性を向上させる自動化された合理的なワークフローへの転換を促しています。さらに、デジタルデータ解析と機械学習アルゴリズムの台頭は、大規模なデータセットの包括的な処理を可能にし、以前は計算の限界のために手の届かなかった洞察を容易にしました。

さらに、標準化されたプロトコールと品質管理手段の広範な採用は、研究と臨床応用の間のギャップを埋めるのに役立っています。この進展は、プロテオミクスが分子レベルでの疾病メカニズムの理解に極めて重要な役割を果たす個別化医療に向けた業界全体の動きを強調するものです。技術革新と合理化されたデータ処理の相互作用は、発見を加速するだけでなく、プロテオミクスサービスを現代のヘルスケアと研究努力に不可欠なツールとして位置づけています。

プロテオミクスサービス市場の主なセグメンテーション洞察

プロテオミクスサービス市場の詳細なセグメンテーションは、このダイナミックな分野を定義する多様な方法論、分析手法、アプリケーションを解明します。市場をタイプ別に分類すると、発現プロテオミクス、機能プロテオミクス、構造プロテオミクスがそれぞれ、全体的な分析ワークフローに独自の貢献をしていることが明らかになります。発現プロテオミクスは、異なる生物学的状態におけるタンパク質の定量と変動に焦点を当て、機能プロテオミクスは、タンパク質の相互作用と機能を理解することを目的としています。一方、構造プロテオミクスは、タンパク質の3次元構造と、それが機能や相互作用に与える影響に関する洞察を提供します。

サンプルの種類によるセグメンテーションを調べると、重要な違いが明らかになります。バイオマーカーが疾患状態を表す可能性のある体液サンプル、細胞内プロセスの探索を可能にする細胞サンプル、病態生理学的な文脈で包括的なプロファイルを提供することが多い組織サンプルなどです。各サンプルタイプには特有の調製ストラテジーと分析方法が要求され、これらはプロテオミクスサービスの選択に影響を与えます。

市場はさらに、バイオインフォマティクスとデータ解析、ケミカル・プロテオミクス解析サービス、タンパク質同定、タンパク質定量、サンプル調製サービスなど、サービスの種類によって細分化されます。これらのサービスが相互に関連することで、生のサンプル処理から実用的な洞察へのシームレスな移行が促進されます。技術もまた基本的な役割を果たしており、クロマトグラフィー、電気泳動、質量分析、タンパク質マイクロアレイ、X線結晶構造解析などの手法が分析をリードしています。特にクロマトグラフィーは、ガスクロマトグラフィーと高速液体クロマトグラフィー（HPLC）が補完的なアプローチを提供し、電気泳動はキャピラリー電気泳動とゲル電気泳動技術によってその有用性を拡大しています。

さらに、市場セグメンテーションでは、農業と食品安全、臨床診断、創薬が大きく貢献していることが強調されています。農業と食品安全では、汚染物質の検出と品質管理が最も重要であり、臨床診断ではプロテオミクスデータをがん診断と感染症評価に活用します。創薬では、バイオマーカー探索と標的同定プロトコールが治療イノベーションを方向付ける。最後に、学術研究機関、受託研究機関、病院、診断研究所、製薬会社、バイオテクノロジー会社などのエンドユーザー部門に焦点を当てることで、プロテオミクスサービスが多様な部門に広く影響を与え、統合されていることを強調しています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • パーソナライズ医療の需要の高まりがプロテオミクス市場の成長を牽引
    • 質量分析とAIの進歩によりタンパク質分析の精度が向上
    • プロテオミクスを促進する創薬とバイオマーカー調査への投資増加
  • 抑制要因
    • 新興市場におけるプロテオミクス技術への高コストとアクセスの制限
  • 機会
    • 早期疾患検出と標的治療におけるプロテオミクスの進歩
    • 臨床診断と精密ヘルスケアにおけるプロテオミクス応用の拡大
  • 課題
    • プロテオミクス技術の複雑な規制基準を世界規模で理解する
• 市場セグメンテーション分析
  • サンプルの種類：体液サンプルの使用が増加し、非侵襲的な診断手順が重視されるようになっている
  • エンドユーザー：パーソナライズ医療への嗜好の高まりが、プロテオミクスサービス市場
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 プロテオミクスサービス市場：タイプ別

• 発現プロテオミクス
• 機能プロテオミクス
• 構造プロテオミクス

第7章 プロテオミクスサービス市場サンプルタイプ別

• 体液サンプル
• 細胞サンプル
• 組織サンプル

第8章 プロテオミクスサービス市場：サービスタイプ別

• バイオインフォマティクスとデータ分析
• 化学プロテオミクス分析サービス
• タンパク質の同定
• タンパク質定量
• サンプル調製サービス

第9章 プロテオミクスサービス市場：技術別

• クロマトグラフィー
  • ガスクロマトグラフィー
  • 高速液体クロマトグラフィー（HPLC）
• 電気泳動
  • キャピラリー電気泳動
  • ゲル電気泳動
• 質量分析
• タンパク質マイクロアレイ
• X線結晶構造解析

第10章 プロテオミクスサービス市場：用途別

• 農業と食品安全
  • 汚染物質の検出
  • 品質管理
• 臨床診断
  • がん診断
  • 感染症診断
• 創薬
  • バイオマーカーの発見
  • ターゲット識別

第11章 プロテオミクスサービス市場：エンドユーザー別

• 学術調査機関
• 契約調査機関
• 病院と診断ラボ
• 製薬・バイオテクノロジー企業

第12章 南北アメリカのプロテオミクスサービス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域のプロテオミクスサービス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカのプロテオミクスサービス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Alphalyse A/S
• Applied Biomics, Inc.
• BGI Group
• Bio-Rad Laboratories, Inc.
• Biogenity ApS
• Biognosys AG
• Bruker Corporation
• CD Genomics
• CovalX AG
• Creative Proteomics
• Danaher Corporation
• Eurofins EAG Materials Sciences LLC
• Evosep ApS
• Illumina, Inc.
• JPT Peptide Technologies GmbH
• Merck KGaA
• Meta Biosciences Pvt Ltd.
• Metware Biotechnology Inc.
• MS Bioworks LLC
• OmicScouts GmbH
• PerkinElmer Inc.
• PolyQuant GmbH
• Proteome Factory AG
• Proteomics International Pty Ltd.
• Rapid Novor Inc.
• Thermo Fisher Scientific Inc
• VProteomics
• Waters Corporation

LIST OF FIGURES

• FIGURE 1. PROTEOMICS SERVICE MARKET MULTI-CURRENCY
• FIGURE 2. PROTEOMICS SERVICE MARKET MULTI-LANGUAGE
• FIGURE 3. PROTEOMICS SERVICE MARKET RESEARCH PROCESS
• FIGURE 4. PROTEOMICS SERVICE MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL PROTEOMICS SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 19. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 23. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 28. PROTEOMICS SERVICE MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 29. PROTEOMICS SERVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. PROTEOMICS SERVICE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL PROTEOMICS SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PROTEOMICS SERVICE MARKET DYNAMICS
• TABLE 7. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY EXPRESSION PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY FUNCTIONAL PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY STRUCTURAL PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY BODY FLUID SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CELL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY BIOINFORMATICS & DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CHEMICAL PROTEOMICS ANALYSIS SERVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY PROTEIN IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY PROTEIN QUANTIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE PREPARATION SERVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC), BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY GEL ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CONTAMINANT DETECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 59. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 60. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 61. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 68. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 69. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 71. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 72. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 73. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 77. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 79. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 80. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 82. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 83. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 84. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. CANADA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. CANADA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 87. CANADA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. CANADA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. CANADA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 90. CANADA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 91. CANADA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. CANADA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 93. CANADA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 94. CANADA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 95. CANADA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 98. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 99. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 101. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 102. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 104. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 105. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 106. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 109. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 110. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 112. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 113. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 115. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 116. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 117. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 119. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 122. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 124. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 125. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 127. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 128. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 129. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 131. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 133. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 134. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 136. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 137. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 139. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 140. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 141. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. CHINA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. CHINA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 144. CHINA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 145. CHINA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. CHINA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 147. CHINA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 148. CHINA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. CHINA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 150. CHINA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 151. CHINA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 152. CHINA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. INDIA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. INDIA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 155. INDIA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 156. INDIA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. INDIA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 158. INDIA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 159. INDIA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. INDIA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 161. INDIA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 162. INDIA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 163. INDIA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 166. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 167. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 169. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 170. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 172. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 173. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 174. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 177. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 178. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 180. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 181. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 183. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 184. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 185. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 188. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 189. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 191. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 192. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 194. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 195. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 196. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 198. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 199. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 200. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 201. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 202. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 203. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 205. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 206. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 207. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 208. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 210. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 212. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 213. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 214. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 216. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 217. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 218. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 219. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 220. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 221. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 222. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 223. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 224. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 225. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 227. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 228. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 229. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 231. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 232. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 233. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 234. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 235. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 236. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 238. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 239. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 240. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 242. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 243. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 244. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 245. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 246. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 247. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 248. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 249. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 250. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 251. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 252. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 253. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 254. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 255. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 256. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 257. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 258. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 259. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 260. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 261. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 262. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 263. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 264. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 265. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 266. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 267. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 268. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 269. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 270. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 271. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 272. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 273. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 274. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 275. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 276. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 277. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 278. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 279. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 280. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 281. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 282. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 283. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 284. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 285. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 286. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 287. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 288. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 289. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 290. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 291. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 292. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 293. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 294. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 295. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 296. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 297. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 298. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 299. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 300. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 301. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 302. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 303. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 304. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 305. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 306. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 307. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 308. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 309. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 310. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 311. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 312. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 313. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 314. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 315. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 316. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 317. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 318. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 319. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 320. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 321. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 322. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 323. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 324. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 325. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 326. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 327. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 328. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 329. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 330. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 331. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 332. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 333. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 334. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 335. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 336. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 337. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
• TABLE 338. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 339. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 340. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 341. ITALY PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 342. ITALY PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 343. ITALY PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 344. ITALY PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY,

The Proteomics Service Market was valued at USD 5.52 billion in 2024 and is projected to grow to USD 6.13 billion in 2025, with a CAGR of 11.34%, reaching USD 10.51 billion by 2030.

Proteomics services have emerged as a critical pillar in modern life sciences and biotechnology, redefining the way we understand cellular processes and disease mechanisms. By analyzing the proteome - the entire set of proteins expressed by an organism - scientists gain valuable insights that drive both fundamental research and clinical applications. In today's fast-paced research environment, proteomics services offer a unique blend of technological innovation and scientific discovery, enabling researchers to decode complex biological systems with unprecedented accuracy.

Recent advancements in analytical techniques, data processing, and high-throughput screening have positioned proteomics at the forefront of personalized medicine, biomarker exploration, and drug discovery. This evolution is not only transforming academic research but is also reshaping the strategies employed by industries such as pharmaceuticals, biotechnology, and clinical diagnostics. As research organizations and commercial enterprises continue to confront intricate biological challenges, the demand for reliable, efficient, and scalable proteomics services has never been higher.

The dynamic nature of this market stems from continual investments in technology and the development of state-of-the-art instrumentation that allows for comprehensive protein analysis. These innovative methods help in precisely identifying and quantifying proteins, thereby opening new avenues for targeted therapeutic interventions. Overall, the ongoing shifts in the proteomics landscape present significant opportunities for stakeholders to drive scientific discovery while simultaneously addressing unmet clinical needs.

Transformative Shifts in the Proteomics Service Landscape

The proteomics services field is undergoing transformative changes that are revolutionizing the way scientific investigations are conducted. Over the past decade, rapid technological advancements have enhanced the precision, scalability, and speed of protein analysis, thereby ushering in a new era of discovery and application. At the heart of these shifts is the integration of cutting-edge instrumentation with robust analytical frameworks that support high-throughput analysis without compromising on reliability.

Innovations such as next-generation mass spectrometry and advanced chromatography techniques have allowed researchers to achieve higher resolution and sensitivity in detecting even the most subtle changes in protein expression. These advances are catalyzing a shift from traditional, manual methods to automated, streamlined workflows that reduce error and improve reproducibility. Furthermore, the rise of digital data analytics and machine learning algorithms has enabled the comprehensive processing of large datasets, facilitating insights that were previously out of reach due to computational limitations.

Additionally, the broader adoption of standardized protocols and quality control measures has helped in bridging the gap between research and clinical applications. This progression underscores an industry-wide move towards personalized medicine, where proteomics plays a pivotal role in understanding disease mechanisms at a molecular level. The interplay between technological innovations and streamlined data handling not only accelerates discoveries but also positions proteomics services as an indispensable tool in modern healthcare and research endeavors.

Key Segmentation Insights in Proteomics Services Market

A detailed segmentation of the proteomics services market elucidates the diverse methodologies, analytical techniques, and applications that define this dynamic field. When categorizing the market based on type, it becomes evident that expression proteomics, functional proteomics, and structural proteomics each contribute uniquely to the overall analysis workflow. Expression proteomics focuses on protein quantification and variation under different biological states, while functional proteomics is geared towards understanding protein interactions and functions. Structural proteomics, on the other hand, provides insights into the three-dimensional conformation of proteins and its implications on function and interaction.

Examining the segmentation by sample type reveals critical distinctions. Studies involve body fluid samples where biomarkers may represent disease states, cell samples that allow the exploration of intracellular processes, and tissue samples which often provide comprehensive profiles in pathophysiological contexts. Each sample type demands specific preparation strategies and analytical methods, which in turn influence the choice of proteomics service.

The market is further segmented by service type, encompassing bioinformatics and data analysis, chemical proteomics analysis services, protein identification, protein quantification, and sample preparation services. The interconnectedness of these offerings facilitates a seamless transition from raw sample processing to actionable insights. Technology also plays a fundamental role, with methods such as chromatography, electrophoresis, mass spectrometry, protein microarray, and X-ray crystallography leading the analytical charge. Here, chromatography is particularly notable, with gas chromatography and high-performance liquid chromatography (HPLC) providing complementary approaches, while electrophoresis extends its utility through capillary electrophoresis and gel electrophoresis techniques.

Furthermore, market application segmentation underlines the significant contributions of agriculture and food safety, clinical diagnostics, and drug discovery. In agriculture and food safety, contaminant detection and quality control are paramount, whereas clinical diagnostics leverage proteomic data for cancer diagnostics and infectious disease evaluations. Drug discovery stands to benefit from biomarker discovery and target identification protocols that direct therapeutic innovation. Finally, the focus on end-user segments such as academic research institutions, contract research organizations, hospitals and diagnostic laboratories, and pharmaceuticals and biotechnology companies underscores the widespread impact and integration of proteomics services across diverse sectors.

Based on Type, market is studied across Expression Proteomics, Functional Proteomics, and Structural Proteomics.

Based on Sample Type, market is studied across Body Fluid Samples, Cell Samples, and Tissue Samples.

Based on Service Type, market is studied across Bioinformatics & Data Analysis, Chemical Proteomics Analysis Service, Protein Identification, Protein Quantification, and Sample Preparation Service.

Based on Technology, market is studied across Chromatography, Electrophoresis, Mass Spectrometry, Protein Microarray, and X-Ray Crystallography. The Chromatography is further studied across Gas Chromatography and High-Performance Liquid Chromatography (HPLC). The Electrophoresis is further studied across Capillary Electrophoresis and Gel Electrophoresis.

Based on Application, market is studied across Agriculture & Food Safety, Clinical Diagnostics, and Drug Discovery. The Agriculture & Food Safety is further studied across Contaminant Detection and Quality Control. The Clinical Diagnostics is further studied across Cancer Diagnostics and Infectious Disease Diagnostics. The Drug Discovery is further studied across Biomarker Discovery and Target Identification.

Based on End-User, market is studied across Academic Research Institutions, Contract Research Organizations, Hospitals & Diagnostic Labs, and Pharmaceuticals & Biotechnology Companies.

Regional Overview of the Global Proteomics Service Market

An evaluation of the proteomics services market from a regional perspective highlights distinct growth trends and investment opportunities across the globe. In the Americas, robust research funding, state-of-the-art infrastructure, and a strong presence of biotechnology firms have made the region a leader in adopting advanced proteomics solutions. This region benefits from a well-established network of research institutions and hospitals that actively collaborate on translational research projects and clinical trials, further bolstering the demand for precision proteomics services.

Moving to Europe, the Middle East, and Africa, there exists a unique blend of innovation driven by governmental support and cross-border research collaborations. European countries are at the forefront of establishing standardized practices and regulatory frameworks that enhance the translation of proteomics research into clinical applications. Meanwhile, emerging markets in the Middle East and Africa are gradually scaling up their research capacities, driven by investments in biotechnology and an increasing awareness of the value of proteomics in addressing regional health challenges.

The Asia-Pacific region represents one of the fastest-growing segments in the global proteomics market. Rapid industrialization, significant public and private investments in research and development, and a burgeoning pharmaceutical sector are key drivers in this region. The collaborative efforts between academic institutions and industry have propelled the adoption of next-generation proteomics tools, fostering a competitive landscape where innovation serves as a critical success factor. Overall, each of these regions brings a unique set of strengths and challenges to the global proteomics services market, creating a multifaceted and ever-evolving landscape.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Industry Players and Their Impact on the Market

The influence of leading companies in the proteomics services sector cannot be overstated, as they drive technological innovation, improve service quality, and expand market reach. Major players such as Agilent Technologies, Inc. and Alphalyse A/S have set high benchmarks by integrating sophisticated analytical instruments with user-friendly software solutions. In parallel, organizations like Applied Biomics, Inc. and BGI Group have been instrumental in developing comprehensive platforms that meld sample processing with cutting-edge data analytics.

The landscape is further enriched by companies like Bio-Rad Laboratories, Inc. and Biogenity ApS, whose practical solutions for protein identification and quantification are widely adopted in both academic and clinical settings. Firms such as Biognosys AG and Bruker Corporation continue to push the boundaries of instrumentation, ensuring that researchers have access to the latest innovations in mass spectrometry and electrophoresis technologies. Other influential names include CD Genomics and CovalX AG, which provide tailored offerings that address specific research needs.

Companies like Creative Proteomics and Danaher Corporation focus on enhancing the reproducibility and scalability of proteomics workflows, while Eurofins EAG Materials Sciences LLC and Evosep ApS excel in streamlining data integration processes. Esteemed organizations including Illumina, Inc., JPT Peptide Technologies GmbH, and Merck KGaA drive collaborative innovation, leveraging their extensive research networks to facilitate breakthroughs in proteomics technologies.

Additional significant contributors such as Meta Biosciences Pvt Ltd., Metware Biotechnology Inc., MS Bioworks LLC, and OmicScouts GmbH are consistently working to reduce turnaround times and improve data fidelity, ensuring that proteomics research remains at the cutting edge. Finally, industry stalwarts like PerkinElmer Inc., PolyQuant GmbH, Proteome Factory AG, Proteomics International Pty Ltd., Rapid Novor Inc., Thermo Fisher Scientific Inc., VProteomics, and Waters Corporation continue to shape market trends through relentless research and innovation, further solidifying the global footprint of proteomics services in both academic and commercial circuits.

The report delves into recent significant developments in the Proteomics Service Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alphalyse A/S, Applied Biomics, Inc., BGI Group, Bio-Rad Laboratories, Inc., Biogenity ApS, Biognosys AG, Bruker Corporation, CD Genomics, CovalX AG, Creative Proteomics, Danaher Corporation, Eurofins EAG Materials Sciences LLC, Evosep ApS, Illumina, Inc., JPT Peptide Technologies GmbH, Merck KGaA, Meta Biosciences Pvt Ltd., Metware Biotechnology Inc., MS Bioworks LLC, OmicScouts GmbH, PerkinElmer Inc., PolyQuant GmbH, Proteome Factory AG, Proteomics International Pty Ltd., Rapid Novor Inc., Thermo Fisher Scientific Inc, VProteomics, and Waters Corporation. Actionable Recommendations for Proteomics Service Market Leaders

For industry leaders aiming to secure a competitive edge in the rapidly evolving proteomics market, clear and decisive steps must be taken. Embracing advanced automation and integrating state-of-the-art instrumentation can dramatically enhance both the speed and accuracy of protein analysis. Leaders should invest in robust data analytics platforms capable of handling large datasets, thus turning raw data into actionable insights that can drive clinical and research innovations.

It is also critical to foster a culture of continuous improvement by engaging in regular training and upskilling of technical teams. This ensures that organizations maintain a high degree of competency and can adapt to new technological advancements with agility. Additionally, forging strategic partnerships with leading research institutions and technology providers can facilitate the adoption of best practices and create symbiotic relationships that benefit both parties.

Further recommendations include the development of flexible service models that can adapt to the diverse requirements of different end-user segments. Industry players should consider modular approaches that allow customization based on specific sample types, analytical techniques, and application domains. Investing in robust quality assurance protocols and complying with international regulatory standards will also enhance credibility and drive market confidence.

Finally, establishing an innovation hub to continuously monitor emerging trends and disruptive technologies can be a cornerstone for future success. This could involve the creation of dedicated research and development units that work in tandem with operational teams, thereby accelerating the translation of innovative solutions from concept to market-ready applications. These actionable measures, when implemented effectively, can serve as a roadmap for sustaining long-term growth and maintaining leadership in the competitive proteomics services landscape.

Conclusion: Embracing the Future of Proteomics Services

The proteomics services market stands at a pivotal juncture where technological advancement, methodological refinement, and strategic positioning converge to define its future trajectory. As comprehensive protein analysis becomes increasingly central to both research and clinical diagnostics, stakeholders must be prepared to adapt to the rapid pace of innovation. The journey from complex data generation to high-impact actionable insights underscores the essential value of proteomics in addressing unmet scientific and medical needs.

The insights drawn from detailed segmentation, regional evaluation, and competitive analysis call for an integrated approach that balances technological investments with market-driven strategies. By prioritizing quality, scalability, and operational excellence, market players can harness the full potential of laboratory automation, advanced analytics, and data integration. Embracing change and continuously reassessing industry practices will be critical to staying ahead in an environment that is dynamic and increasingly data-centric.

Ultimately, the drive toward precision medicine and personalized therapies will only intensify the demand for superior proteomics services. It is incumbent upon industry leaders to not only recognize these opportunities but to also act decisively in transforming early-stage innovations into market-ready solutions. The future of proteomics is bright, offering unparalleled prospects for advancing our understanding of biology and revolutionizing healthcare.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising demand for personalized medicine driving proteomics market growth
    • 5.1.1.2. Advancements in mass spectrometry and AI enhancing protein analysis precision
    • 5.1.1.3. Increased investment in drug discovery and biomarker research boosting proteomics
  • 5.1.2. Restraints
    • 5.1.2.1. High costs and limited access to proteomics technologies in emerging markets
  • 5.1.3. Opportunities
    • 5.1.3.1. Proteomics advancements in early disease detection and targeted therapies
    • 5.1.3.2. Expansion of proteomics applications in clinical diagnostics and precision healthcare
  • 5.1.4. Challenges
    • 5.1.4.1. Navigating complex regulatory standards for proteomics technologies globally
• 5.2. Market Segmentation Analysis
  • 5.2.1. Sample Type: Growing use of body fluid samples with increasing emphasis on non-invasive diagnostic procedures
  • 5.2.2. End-User: Rising preference towards personalized medicine boosting the proteomics service market
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Proteomics Service Market, by Type

• 6.1. Introduction
• 6.2. Expression Proteomics
• 6.3. Functional Proteomics
• 6.4. Structural Proteomics

7. Proteomics Service Market, by Sample Type

• 7.1. Introduction
• 7.2. Body Fluid Samples
• 7.3. Cell Samples
• 7.4. Tissue Samples

8. Proteomics Service Market, by Service Type

• 8.1. Introduction
• 8.2. Bioinformatics & Data Analysis
• 8.3. Chemical Proteomics Analysis Service
• 8.4. Protein Identification
• 8.5. Protein Quantification
• 8.6. Sample Preparation Service

9. Proteomics Service Market, by Technology

• 9.1. Introduction
• 9.2. Chromatography
  • 9.2.1. Gas Chromatography
  • 9.2.2. High-Performance Liquid Chromatography (HPLC)
• 9.3. Electrophoresis
  • 9.3.1. Capillary Electrophoresis
  • 9.3.2. Gel Electrophoresis
• 9.4. Mass Spectrometry
• 9.5. Protein Microarray
• 9.6. X-Ray Crystallography

10. Proteomics Service Market, by Application

• 10.1. Introduction
• 10.2. Agriculture & Food Safety
  • 10.2.1. Contaminant Detection
  • 10.2.2. Quality Control
• 10.3. Clinical Diagnostics
  • 10.3.1. Cancer Diagnostics
  • 10.3.2. Infectious Disease Diagnostics
• 10.4. Drug Discovery
  • 10.4.1. Biomarker Discovery
  • 10.4.2. Target Identification

11. Proteomics Service Market, by End-User

• 11.1. Introduction
• 11.2. Academic Research Institutions
• 11.3. Contract Research Organizations
• 11.4. Hospitals & Diagnostic Labs
• 11.5. Pharmaceuticals & Biotechnology Companies

12. Americas Proteomics Service Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Proteomics Service Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Proteomics Service Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Illumina collaborates with UK Biobank to advance proteomics with a comprehensive pilot program analyzing 50,000 samples
  • 15.3.2. Quantum-Si's Platinum Pro revolutionizes proteomics with a user-friendly, customizable sequencing platform
  • 15.3.3. Strategic acquisition of Olink by Thermo Fisher Scientific enhances its presence in innovative proteomics services
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Alphalyse A/S
• 3. Applied Biomics, Inc.
• 4. BGI Group
• 5. Bio-Rad Laboratories, Inc.
• 6. Biogenity ApS
• 7. Biognosys AG
• 8. Bruker Corporation
• 9. CD Genomics
• 10. CovalX AG
• 11. Creative Proteomics
• 12. Danaher Corporation
• 13. Eurofins EAG Materials Sciences LLC
• 14. Evosep ApS
• 15. Illumina, Inc.
• 16. JPT Peptide Technologies GmbH
• 17. Merck KGaA
• 18. Meta Biosciences Pvt Ltd.
• 19. Metware Biotechnology Inc.
• 20. MS Bioworks LLC
• 21. OmicScouts GmbH
• 22. PerkinElmer Inc.
• 23. PolyQuant GmbH
• 24. Proteome Factory AG
• 25. Proteomics International Pty Ltd.
• 26. Rapid Novor Inc.
• 27. Thermo Fisher Scientific Inc
• 28. VProteomics
• 29. Waters Corporation